These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 2240167)

  • 1. Cyclocreatine inhibits the production of neutrophil chemotactic factors from isolated hearts.
    Elgebaly SA; Allam ME; Rossomando EF; Cordis GA; Forouhar F; Farghaly A; Kreutzer DL
    Am J Pathol; 1990 Nov; 137(5):1233-41. PubMed ID: 2240167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclocreatine inhibits neutrophil accumulation in the myocardium of a canine model of coronary artery occlusion and reperfusion.
    Elgebaly SA; Allam ME; Houser S; Hashmi F; Forouhar F; Miano D
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1670-7. PubMed ID: 8371165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac derived neutrophil chemotactic factors; preliminary biochemical characterization.
    Elgebaly SA; Masetti P; Allam M; Forouhar F
    J Mol Cell Cardiol; 1989 Jun; 21(6):585-93. PubMed ID: 2674454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac-derived neutrophil chemotactic factors: detection in coronary sinus effluents of patients undergoing myocardial revascularization.
    Elgebaly SA; Hashmi FH; Houser SL; Allam ME; Doyle K
    J Thorac Cardiovasc Surg; 1992 May; 103(5):952-9. PubMed ID: 1314922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of creatine monohydrate on cardiac function in a rat model of endotoxemia.
    Vona-Davis L; Wearden PD; Karne NH; Hill RC
    J Surg Res; 2002 Mar; 103(1):1-7. PubMed ID: 11855910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ionic basis of chemotaxis. Separate cation requirements for neutrophil orientation and locomotion in a gradient of chemotactic peptide.
    Marasco WA; Becker EL; Oliver JM
    Am J Pathol; 1980 Mar; 98(3):749-68. PubMed ID: 6767408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil chemotactic factors in the tears of giant papillary conjunctivitis patients.
    Elgebaly SA; Donshik PC; Rahhal F; Williams W
    Invest Ophthalmol Vis Sci; 1991 Jan; 32(1):208-13. PubMed ID: 1846131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of temperature on myocardial calcium homeostasis and mitochondrial function during ischemia and reperfusion.
    Ferrari R; Raddino R; Di Lisa F; Ceconi C; Curello S; Albertini A; Nayler W
    J Thorac Cardiovasc Surg; 1990 May; 99(5):919-28. PubMed ID: 2329831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
    Harvath L; Yancey KB; Katz SI
    J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial protection during ischemia by prior feeding with the creatine analog: cyclocreatine.
    Jacobstein MD; Gerken TA; Bhat AM; Carlier PG
    J Am Coll Cardiol; 1989 Jul; 14(1):246-51. PubMed ID: 2738267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immature and the mature myocardium. Responses to multidose crystalloid cardioplegia.
    Magovern JA; Pae WE; Miller CA; Waldhausen JA
    J Thorac Cardiovasc Surg; 1988 Apr; 95(4):618-24. PubMed ID: 3352295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium.
    Baker JE; Boerboom LE; Olinger GN
    J Thorac Cardiovasc Surg; 1988 Nov; 96(5):717-24. PubMed ID: 3184966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of myocardial protection from ischemic arrest by intracoronary tetrodotoxin administration.
    Tyers GF; Todd GJ; Neely JR; Waldhausen JA
    J Thorac Cardiovasc Surg; 1975 Feb; 69(2):190-5. PubMed ID: 1113537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is protection of ischemic neonatal myocardium by cardioplegia species dependent?
    Baker JE; Boerboom LE; Olinger GN
    J Thorac Cardiovasc Surg; 1990 Feb; 99(2):280-7. PubMed ID: 2299865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creatine and cyclocreatine effects on ischemic myocardium: 31P nuclear magnetic resonance evaluation of intact heart.
    Osbakken M; Ito K; Zhang D; Ponomarenko I; Ivanics T; Jahngen EG; Cohn M
    Cardiology; 1992; 80(3-4):184-95. PubMed ID: 1511465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxynitrite, a two-edged sword in post-ischemic myocardial injury-dichotomy of action in crystalloid- versus blood-perfused hearts.
    Ma XL; Gao F; Lopez BL; Christopher TA; Vinten-Johansen J
    J Pharmacol Exp Ther; 2000 Mar; 292(3):912-20. PubMed ID: 10688604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
    Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of cardioprotection against ischemia/reperfusion injury by valsartan: an experiment with isolated rat hearts].
    Zhang YJ; Bai XJ; Qi ZM; Wang HX
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3350-3. PubMed ID: 16409843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
    Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
    J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotection with pioglitazone is abolished by nitric oxide synthase inhibitor in ischemic rabbit hearts--comparison of the effects of pioglitazone and metformin.
    Kawabata H; Ishikawa K
    Diabetes Metab Res Rev; 2003; 19(4):299-305. PubMed ID: 12879407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.